Plasma fetuin-A is associated with type 2 diabetes, and AHSG, the gene encoding fetuin-A, has been identified as a susceptibility locus for diabetes and metabolic syndrome. Thus far, unbiased investigations of the genetic determinants of plasma fetuin-A concentrations have not been conducted. We searched for single nucleotide polymorphisms (SNPs) related to fetuin-A concentrations by a genome-wide association study in six population-based studies.
Introduction
Fetuin-A is a liver-derived protein that is involved in the metabolism of calcified minerals and the regulation of the insulin signaling (1) . Fetuin-A forms complexes with circulating calcium and phosphorus and increases the solubility of these minerals (2) , thereby inhibiting arterial calcium deposition. Fetuin-A also directly binds and inhibits the insulin receptor, resulting in insulin resistance (3) (4) (5) . The fetuin-A knock-out mouse has improved insulin sensitivity by euglycemic clamp experiments, lower triglyceride and free fatty acid levels, resistance to weight gain, and less adiposity (6, 7) . High fetuin-A levels are associated with insulin resistance (8) (9) (10) , interacts with circulating free fatty acids in determining insulin sensitivity and predicts incident diabetes (11) (12) (13) (14) (15) (16) . Thus, fetuin-A represents an emerging biomarker for improved diabetes risk assessment in clinical practice and a potential therapeutic target for primary or secondary prevention of type 2 diabetes.
The alpha-2-HS-glycoprotein (AHSG) locus on chromosome 3 (3q27) encodes the fetuin-A gene. Linkage studies have identified this region as a susceptibility locus for the metabolic syndrome and T2DM (17, 18) , and small case-control studies have reported strong relations between several single nucleotide polymorphisms (SNPs) identified from direct exon sequencing studies and plasma concentrations of fetuin-A (19) (20) (21) (22) . However, a comprehensive investigation of genetic determinants of fetuin-A levels has not been conducted, and it remains unknown if genetic loci distinct from the AHSG locus can be identified that regulate fetuin-A concentrations. Hence, to better understand the genetic control of fetuin-A levels we conducted a genome-wide association (GWA) analysis in six population-based studies, as part of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.
Results
Our analyses included data from six studies of European Americans totaling 9,055 individuals and four studies comprising a total of 2,119 African Americans. The majority of the participants were female and the average age ranged from 52 years in ARIC to 75 years in CHS. Mean fetuin-A levels ranged from 0.43 6 0.09 g/l in African Americans from CHS to 1.00 6 0.41 g/l in European Americans in HABC. However, most studies had smaller standard deviations than HABC and mean fetuin-A levels averaged around 0.50 g/l (Table 1) .
Separate meta-analyses of 2.5 million SNPs for European and African American participants who contributed to the study-specific genome-wide association analyses of fetuin-A levels, identified a very strong signal on chromosome 3q27 (Fig. 1, Supplementary Material, Fig. S1 ). In total, 136 SNPs at the AHSG locus achieved genome-wide significance among European Americans. The top SNP, rs4917 (P-value ¼1.27Â10 À303 ), is located in the AHSG gene which encodes the fetuin-A protein.
The genetic region and the linkage disequilibrium (LD) of SNPs with rs4917 according to r 2 in CEU are displayed in Supplementary Material, Figure S2A and B. The triangles represent the top two non-synonymous SNPs (rs4917 in purple and rs4918 in red). Detailed results on the 136 SNPs are available in the online Supplementary Material, Table S3 . Though the list of genes in closest proximity to the SNPs includes FETUB, CRYGS, DNAJB11, KGN1, and TBCCD1, these genes are all within close distance to AHSG, as shown in Supplementary Material, Figure S2A . Each additional copy of the rs4917 minor allele (T variant allele, minor allele frequency ¼0.32) was associated with approximately 0.066 60.002 g/l lower fetuin-A level in each of the cohorts (Table 2 ). rs4917 alone explained 14% of the variation in fetuin-A levels among European Americans.
The plots in Supplementary Material, Figure S2 show that the strongest associations are centered in a region with a high degree of LD. However, as shown in Supplementary Material, Figure S2B , five of the SNPs with extremely low P-values (< 5Â10
À235
) were not in strong LD with rs4917/rs4918 (light blue shaded dots, Supplementary Material, Fig. S2B ). These five SNPs (rs13098866, rs13080283, rs2077119, rs1029353, and rs2070635) were instead in tight LD with each other (r 2 < 0.6). Further, when we repeated the genome-wide association analyses conditioning on rs4917 to uncover any additional, independently associated SNPs, 34 SNPs at the AHSG locus were associated with fetuin-A concentrations (P< 5Â10 À8 ). The five SNPs from Supplementary Material, Figure S2B were among the SNPs that remained strongly statistically significantly associated with fetuin-A levels in this analysis (all P < 5Â10 À28 in the conditional analysis). Among the 34 SNPs, ten SNPs were new hits (P <5Â10 À8 in the conditional analysis only). The 10 SNPs were not in LD with rs4917, indicating that the strong association Diabetes was defined as fasting blood glucose >125 mg/dL, a random blood glucose of >200 mg/dL, or use of insulin or oral hypoglycemic agents. with fetuin-A levels observed for the AHSG locus stems from more than a single hit (Data for the 10 SNPs shown in Table 3 ). The Manhattan plot for European Americans also shows that other associations on chromosome 3 were elevated, though still not statistically significant upon adjustment for rs4917 (Supplementary Material, Fig. S5 ). The AHSG locus also had the strongest association in the metaanalysis of four genome-wide studies that contributed data from 2,119 African American participants (Fig. 2, Supplementary  Material, Fig. S3 ). In total, 42 SNPs at the AHSG locus were associated with fetuin-A levels with p values < 5Â10
À8 among the African Americans (Supplementary Material, Fig. S4 and Table S4 ). Each copy of the rs4917 minor allele was associated with 0.041 60.003 g/l lower fetuin-A concentration (P-value ¼ 1.20Â10
À34
) and this variant alone explained 13% of the variation in fetuin-A levels, but another AHSG variant (rs1900618) was the top SNP in the genome-wide analysis of the African American samples. rs4917 and rs1900618 are in complete LD according to D' from HapMap YRI population, but the two SNPs were only moderately correlated (r 2 ¼0.57) and had slightly different MAFs in African American participants only (0.26 versus 0.33). In contrast, both D j and r 2 were nearly 1 in HapMap CEU. Overall, Supplementary Material, Figure  S4 shows the extent of LD was less pronounced among African American participants. Of note the five variants that were in tight LD with each other but not with rs4917/rs4918 were also among the genome-wide significant SNPs in African Americans (Supplementary Material, Table S4 ). Because of the modest correlation of rs4917 with just a handful of the 42 fetuin-A associated SNPs, the SNPs that were significant in the conditional analyses (conditioning on rs4917) mostly overlapped with the significant SNPs in the unconditional analyses (Supplementary Material, Fig.  S6 ). Two exceptions were rs1486336 and rs958629 that reached significance only in the conditional analysis (and had borderline p values in the unconditional analysis (P $1Â10
À7
).
Discussion
Very little is known about the genetic determination of circulating fetuin-A levels, a marker of diabetes and the metabolic syndrome. To our knowledge, the present study represents the first unbiased genome-wide search for genetic variants associated with fetuin-A concentrations. In the present paper, all of the major genetic determinants of fetuin-A levels were located in the fetuin-A encoding gene; AHSG. We further provide evidence that the genetic variation of importance to fetuin-A In both ethnicities, variants in and near the AHSG locus showed the strongest associations with fetuin-A levels. The most highly associated SNPs in the two ethnicities were not identical (rs4917 in European and rs1900618 in AfricanAmericans), but showed remarkably similar associations that were in close proximity (within 1 kb distance) and were in very high linkage disequilibrium, suggesting that they may mark the same causal variant. Though the top association was different (rs1900618) among African American participants, the high degree of LD in this region does not allow for conclusions on the potential causal variant marked by these SNPs. Interestingly, genetic variation in AHSG has not been examined in African American samples before.
We found that rs4917 alone explained 14% of the variation in fetuin-A in European and 13% in African Americans individuals. In comparison, genome-wide association studies have identified several genetic loci that contribute to the levels of other biomarkers such as fibrinogen, CRP or adiponectin. Multigenetic risk scores that include all the independent genome-wide significant loci for each of these traits (e.g. up to 23 independent loci for fibrinogen) have been found to explain < 4% of the variation in fibrinogen and up to 5% for CRP and adiponectin (23) (24) (25) .
When placed in the context of previous studies, several of the over 100 variants with genome-wide significant associations in our analysis have been identified previously. In particular, rs4917 and rs4918 are both missense variants located in the last two exons of the AHSG gene (exons 6 and 7, respectively) (26) (27) (28) . Both SNPs have been associated with a similar magnitude of difference in plasma fetuin-A as observed in our study (0.06 6 0.002 g/l lower levels in variant carriers) (22) . While rs4917 and rs4918 do not appear to be related to metabolic markers including insulin levels, lipids, BMI, and fasting glucose in other studies (20, (28) (29) (30) associations with risk of cardiovascular disease have been reported for both general (22, 31) and renal patient populations (32) . A potential regulatory function stemming from the coding regions harboring rs4917 and rs4918 thus warrants further study.
In genome-wide analysis conditioning on rs4917, we identified 34 SNPs that were genome-wide significant in European Americans. Five SNPs were also significant in the main analysis (rs13098866, rs13080283, rs2077119, rs1029353, and rs2070635) because they were not in LD with rs4917, but in high LD with each other. Among these, rs2077119 in the 5 0 untranslated region has previously been found to be associated with markers of insulin resistance in adipocytes (28), and with the risk of diabetes (20) . A borderline association with risk of CHD has been reported for the intron variant rs2070635 (22) . Another ten SNPs were only significantly associated with plasma fetuin-A levels in the analysis conditioned on rs4917. These 10 SNPs were in LD with rs2077119 (D 0 > 0.7 in HapMap CEU).
In conclusion, genetic variation in AHSG is strongly associated with fetuin-A levels. While we cannot exclude the possibility that other genetic loci play a role in fetuin-A concentrations, our sample size of over 9,000 European and 2,000 African Americans identified SNPs in the AHSG with P-values for their association lower than 1Â10 À300 indicating a very low chance that this is a false positive finding and highlighting the power inherent in analyses of this trait. Further work is needed to identify the functional variants and to understand the underlying biology of these associations. Our finding of a strong link between AHSG SNPs and fetuin-A levels provide a useful framework for the continued investigation of the causal variants in the AHSG gene. 
Materials and Methods
We used data on genetic variation and fetuin-A levels from six population-based studies from the U.S. The following studies from the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium were included: Atherosclerosis Risk in Communities Study (ARIC), the Cardiovascular Health Study (CHS), the Multi-Ethnic Study of Atherosclerosis (MESA), and the Framingham Heart Study. In addition, investigators from the Health, Aging, and Body Composition (Health ABC) and Nurses' Health Study contributed data. Local ethical committees at each institution approved the individual study protocols. Detailed methods of each study population are included in the online supplement. Various genotyping platforms were used by the different studies, however, all studies imputed their genotyped data to HapMap release 22 CEU and YRI reference panels. Details on genotyping platform, quality control and imputation specifics are available in online in Supplementary Materials, Tables S1 and S2.
Fetuin-A measures
Fetuin-A was measured in plasma using enzyme linked immunosorbent assays (ELISA) from Epitope Diagnostics, San Diego, CA (CHS, MESA, HABC, and ARIC), Biovendor, Candler, NC (FHS), or from R&D Systems, Minneapolis, MN (NHS). Each study reported CV's < 14%.
Statistical analysis
The associations between genotypes and fetuin-A level were analyzed within each cohort using linear regression in an additive model. All analyses were adjusted for age, sex, eigenvectors for population stratification, and if applicable, field center. Analyses were conducted separately for European and African Americans. See details for study-specific methods in Supplementary Material, Tables S1 and S2.
To combine results across cohorts, we performed an inverse variance-weighted meta-analysis using the software package METAL (38) . Cohort-specific standard errors were adjusted using genomic control. In GWAS, we chose P ¼ 5 Â 10 À8 as the threshold for significance (39) . To investigate whether the multiple SNPs associated in the respective region were due to linkage disequilibrium (LD) with the top SNP or if multiple independent signals existed, we performed a meta-analysis based on models conditioned on the SNP with the smallest P-value.
To assess the variation in fetuin-A levels explained by our top SNPs, we compared the r 2 values from a model with just basic covariates versus a model that also included rs4917.
Supplementary Material
Supplementary Material is available at HMG online. 
